MET vs NKTX · P/E 13, rev $38.23B vs $188.9M cap
MetLife Inc (MET) versus Nkarta Inc (NKTX) — a side-by-side from cached financials, not a winner call.
MetLife Inc (MET) is a insurance - life company listed on US.
Nkarta Inc (NKTX) is a biotechnology company listed on NASDAQ.
Latest reported MET revenue for 2026-06-30 was $38.23B. Net income was $1.92B. MET currently screens at market cap $52.16B and trailing P/E 12.7.
Latest reported NKTX revenue for 2025-12-31 was $0. Net income was -$104.1M. NKTX currently screens at market cap $188.9M.
MET currently screens at market cap $52.16B and trailing P/E 12.7. NKTX currently screens at market cap $188.9M.
Not investment advice. Open the MET and NKTX stock pages for the full models.
Not investment advice.